RxDoctor Payments Data

Joseph Poole, NP

Nurse Practitioner · Santa Fe, NMNPI 1457712549

Payments from drug & device makers

$1,390in general payments, 2019–2025

Across 77 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$383
  • Amgen$296
  • AstraZeneca$198
  • GSK$167
  • UCB, Inc.$86
  • Lilly USA, LLC$63
  • plus $197 from 7 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,390 in reported general payments places this provider in the 90th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$178,366
Medicare patients
143
Services billed
11,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf)Adalimumab18$129,857
RinvoqUpadacitinib11$111,017
Cosentyx Sensoready (2 Pens)Secukinumab14$103,800
KevzaraSarilumab20$80,232
Humira(Cf) PenAdalimumab11$74,413
OtezlaApremilast13$60,064
Hydroxychloroquine Sulfate261$10,105
Leflunomide66$6,013
MethotrexateMethotrexate Sodium156$4,837
Prednisone189$1,666
Colchicine16$1,065
Celecoxib33$916
Duloxetine Hcl14$470
Alendronate Sodium30$439
Gabapentin28$354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf), Rinvoq$383$240,87429 claims
AmgenOtezla$296$60,06413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 nurse practitioner providers in New Mexico.

Other nurse practitioner in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →